Ružauskas, Modestas; Šiugždinienė, Rita; Šeputienė, Vaida; Sužiedėlienė, Edita; Virgailis, Marius; Daugelavičius, Rimantas; Špakauskas, Vytautas; Zienius, Dainius; Šengaut, Jakov; Pavilonis, Alvydas
June 2010
Veterinarija ir Zootechnika;2010, Vol. 50 Issue 72, p73
Academic Journal
The aim of this study was to determine minimal inhibitory concentration (MIC) values of Escherichia coli and Salmonella enterica as the most important bacteria family Enterobacteriaceae and to evaluate their clinical and epidemiological resistance to quinolones and fluoroquinolones. One hundred and thirty seven strains of Escherichia coli and 75 strains of Salmonella enterica from different species of animals from different farms (cattle, pigs and poultry) were tested for susceptibility. Nalidixic acid and ciprofloxacin were selected as representatives of quinolones and fluoroquinolones respectively. Results showed that total clinical resistance of E. coli isolated from clinical material of animals to nalidixic acid was 44.5%, to ciprofloxacin - and 34.4%. In addition, 22.0% of total E. coli were highly resistant to nalidixic acid with MIC value of 256 mg/L and 12.0% of E. coli MIC values to ciprofloxacin were also high - 8 mg/L. S. enterica demonstrated frequent resistance to nalidixic acid (41.3%) however only 5.3% were resistant to ciprofloxacin with lowest breakpoint value - 0.5 mg/L. E. coli isolates from poultry showed to be more frequent resistant to quinolones and fluoroquinolones. Cattle isolates had the lowest frequency of resistance. Epidemiological susceptibility was counted according to cut-off values (EUCAST). Results showed that 53.0% of E. coli had MIC values higher than epidemiological cut-off values to nalidixic acid and 34.0% - to ciprofloxacin. 41.0% of Salmonella were epidemiologically resistant to both nalidixic acid and ciprofloxacin and that fact may demonstrate increasing resistance of Salmonella to fluoroquinolones.


Related Articles

  • Effect of the efflux pump QepA2 combined with chromosomally mediated mechanisms on quinolone resistance and bacterial fitness in Escherichia coli. Machuca, Jesús; Briales, Alejandra; Díaz-de-Alba, Paula; Martínez-Martínez, Luis; Pascual, Alvaro; Rodríguez-Martínez, José-Manuel // Journal of Antimicrobial Chemotherapy (JAC);Sep2015, Vol. 70 Issue 9, p2524 

    Objectives: The aim of the study was to determine the interplay between the plasmid-mediated qepA2 gene and multiple chromosomally mediated fluoroquinolone resistance determinants in the development of fluoroquino-lone resistance in Escherichia coli and its influence on bacterial fitness....

  • Smqnr VARIANTS IN CLINICAL ISOLATES OF Stenotrophomonas maltophilia IN BRAZIL. GRACIA-PAEZ, Jourge Isaac; FERRAZ, Juliana Rosa; SILVA, Ivan Avelino FRANÇA E.; ROSSI, Flavia; LEVIN, Anna Sara; COSTA, Silvia Figueiredo // Revista do Instituto de Medicina Tropical de Sao Paulo;Nov/Dec2013, Vol. 55 Issue 6, p417 

    Stenotrophomonas maltophilia contains a novel chromosomally-encoded qnr gene named Smqnr that contributes to low intrinsic resistance to quinolone. We described Sm qnr in 13 clinical isolates of S. maltophilia from two Brazilian hospitals, over a 2-year period. The strains were identified by API...

  • Molecular epidemiological survey on quinolone resistance genotype and phenotype of Escherichia coli in septicemic broilers in Hebei, China. Xie, Rong; Huo, Shuying; Li, Yurong; Chen, Ligong; Zhang, Feiyan; Wu, Xianjun // Poultry Science;Feb2014, Vol. 93 Issue 2, p335 

    In this study, the quinolone-resistant determining region (QRDR) of gyrA of Escherichia coli and plasmid-mediated quinolone resistance (PMQR) genes, qnr(qnrA, qnrB, and qnrS), and aac(6 ′)-Ib-cr were detected, sequenced, and analyzed. In addition, antimicrobial susceptibility tests (using...

  • Ciprofloxacin Dosage and Emergence of Resistance in Human Commensal Bacteria. Fantin, Bruno; Duval, Xavier; Massias, Laurent; Alavoine, Loubna; Chau, Françoise; Retout, Sylvie; Andremont, Antoine; Mentré, France // Journal of Infectious Diseases;8/1/2009, Vol. 200 Issue 3, p390 

    Background. Although optimization of the fluoroquinolone dosage increases the efficacy of this class of drugs against bacterial infections, its impact on the emergence of resistance in commensal bacteria is unknown. Methods. Six different 14-day dosages of oral ciprofloxacin were randomly...

  • New study finds dysglycemia risk. Elliott, William T. // Neurology Alert;Oct2013 Pharmacology Watch, p1 

    The article discusses a study from Taiwan which examined diabetic patients who received fluoroquinolones antibiotics. These patients were also monitored for dysglycemia risk including hyperglycemia and hypoglycemia. The article also cites the association of fluoroquinolones such as levofloxacin,...

  • Is nalidixic acid screening still valid for the detection of reduced susceptibility of fluoroquinolone with SalmonellaTyphi? Irfan, Seema; Jabeen, Kauser; Jilani, Umair Anwar; Ahmed, Bushra; Mehraj, Jaishri; Ahsan, Tanwir; Zafar, Afia // Journal of Infection in Developing Countries;Oct2012, Vol. 6 Issue 10, p700 

    Introduction: Considering the limitations of screening with nalidixic acid to detect reduced susceptibility to fluoroquinolones of Salmonella enterica serovar Typhi (S.Typhi) strains, we evaluated the use of a 30 µg nalidixic acid disc screening method in Pakistan. Methodology: Non duplicate...

  • Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals. Adam, Heather J.; Baxter, Melanie R.; Davidson, Ross J.; Rubinstein, Ethan; Fanella, Sergio; Karlowsky, James A.; Lagacé-Wiens, Philippe R. S.; Hoban, Daryl J.; Zhanel, George G. // Journal of Antimicrobial Chemotherapy (JAC);May2013 Supplement, Vol. 68 Issue suppl_1, pi31 

    Objectives The purpose of this study was to describe the association between age groups and antimicrobial resistance in the most commonly identified pathogens in Canadian hospitals. Methods Between 2007 and 2011, 27 123 clinically significant isolates, comprising 3580 isolates from children...

  • Microbial transformations of antimicrobial quinolones and related drugs. Parshikov, Igor; Sutherland, John // Journal of Industrial Microbiology & Biotechnology;Dec2012, Vol. 39 Issue 12, p1731 

    The quinolones are an important group of synthetic antimicrobial drugs used for treating bacterial diseases of humans and animals. Microorganisms transform antimicrobial quinolones (including fluoroquinolones) and the pharmacologically related naphthyridones, pyranoacridones, and cinnolones to a...

  • A Good Choice for Treating Bacterial Conjunctivitis. McCabe, Cathleen // Review of Ophthalmology;Jan2014, Vol. 21 Issue 1, p14 

    The article discusses the study conducted in the U.S. on fluoroquinoione antibiotic as treatment for bacterial conjunctivitis. The clinical data of quinolone anfimicrobial, BESIVANCE, is tackled, along with its efficacy and risk information. The case of a 82-year-old woman presented with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics